Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir. - Cherry CL; Hoy JF; Rowe JS; Krum H; Mills J; Lewin SR (Current HIV research, 2008)